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Mycobacterium avium subspecies hominissuis (MAH) is the most common agent causing 
nontuberculous mycobacterial disease in humans. It mainly causes chronic and slowly 
progressive pulmonary disease (PD), which requires a long-term treatment and allows 
opportunistic co-infection by common pulmonary pathogens such as Pseudomonas 
aeruginosa, Staphylococcus aureus, and Aspergillus spp., thereby resulting in alteration 
of host immune response. In the present study, we investigated the phenotypical and 
functional alterations of dendritic cells (DCs), a bridge antigen-presenting cell between 
innate and adaptive immunity, following MAH infection in response to various toll-like 
receptor (TLR) agonists mimicking co-infection conditions, along with subsequent T cell 
response. Interestingly, MAH-infected DCs produced interleukin (IL)-10 significantly and 
decreased the level of IL-12p70  in response to Poly I:C and LPS, although not so in 
response to Pam3CSK4, imiquimod, or CpG oligodeoxynucleotide, thereby indicating 
that the TLR3 and TLR4 agonists functionally altered MAH-infected DCs toward a 
tolerogenic phenotype. Moreover, IL-10-producing tolerogenic DCs were remarkably 
induced by MAH and P. aeruginosa co-infection. To precisely elucidate how these TLR 
agonists induce tolerogenic DCs upon MAH infection, we sought to clarify the major 
mechanisms involved, using LPS, which caused the greatest increase in IL-10 production 
by the TLR agonists. Increased IL-10 stimulated the creation of tolerogenic DCs by 
significantly reducing MHC class II expression and MHC class II-antigen presentation, 
eventually inhibiting CD4+ T cell proliferation, along with decreased IFN-γ and IL-2. The 
tolerogenic phenotypes of MAH/LPS-treated DCs were restored by anti-IL-10 neutralization, 
validating the induction of tolerogenicity by IL-10. Interestingly, IL-10-producing-tolerogenic 
DCs were observed after infection with live MAH, rather than with inactivated or dead 
MAH. In addition, TLR2−/− and TLR4−/− DCs confirmed the association of IL-10 production 
with TLR2 and TLR4 signaling; IL-10 production synergistically increased when both TLR4 
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INTRODUCTION
Mycobacterium avium subspecies hominissuis (MAH), which 
belongs to the M. avium complex (MAC), is emerging as an 
important pathogen in pulmonary diseases (PD) caused by 
nontuberculous mycobacterial (NTM) infection in humans, 
despite the decreasing incidence of tuberculosis globally (Prevots 
and Marras, 2015; Meier et al., 2017). The prevalence of chronic 
lung diseases, such as chronic obstructive pulmonary disease 
(COPD), cystic fibrosis (CF), and bronchiectasis, and HIV 
infection have increased, and the use of immunosuppressive 
medication has increased, resulting in increased frequency of 
NTM infection (Thomson, 2010; Bonaiti et al., 2015). Recently, 
patients with NTM-PD were seen to be  frequently co-infected 
with other NTM species or microorganisms (Wickremasinghe 
et  al., 2005; Kunst et  al., 2006; Fujita et  al., 2014; Bonaiti 
et al., 2015). Especially, Pseudomonas aeruginosa (P. aeruginosa) 
has been reported to range from 27 to 52% and is the most 
frequent co-infection with NTM (Wickremasinghe et  al., 2005; 
Zoumot et  al., 2014; Bonaiti et  al., 2015). According to 
Wickremasinghe et  al. (2005), P. aeruginosa was isolated in 
52% of patients co-infected with NTM in a retrospective analysis 
of 100 patients with bronchiectasis (Wickremasinghe et  al., 
2005). Staphylococcus aureus (28%), Haemophilus influenzae 
(12%), Candida albicans (8%), Aspergillus fumigatus (4%), and 
Stenotrophomonas maltophilia (4%) were the other frequent 
co-pathogens in the same study (Wickremasinghe et  al., 2005; 
Bonaiti et  al., 2015). Fujita et  al. (2014) identified pathogenic 
co-infection of non-MAC pathogens, isolated from the sputum 
samples of 275 patients with MAC-PD between 2001 and 2013; 
45.1, 14.9, and 40% patients with MAC-PD showed chronic, 
intermittent, and no co-infection, respectively (Fujita et  al., 
2014). The main co-infecting microorganisms from the above 
findings were S. aureus, P. aeruginosa, and Aspergillus spp. in 
higher order (Fujita et  al., 2014). In particular, these three 
major microorganisms chronically infected patients with 
MAC-PD, accounting for 71.9% of S. aureus infection, 77.8% 
of P. aeruginosa infection, and 62.1% of Aspergillus spp. infection 
(Fujita et  al., 2014). P. aeruginosa was reported to be  more 
frequently isolated during MAC treatment (75%) or after MAC 
sputum conversion (93.1%) than during MAC-positive 
sputum culture (25.7%) (Fujita et  al., 2014). This implies that 
P. aeruginosa may be  able to infect intermittently, but the 
most P. aeruginosa infection can affect chronically patients with 
MAC (Fujita et al., 2014). Chronic co-infection of P. aeruginosa 
is known to be  associated with a wide range of lesions in the 
lower lobe of lung and can affect lung function and disease 
severity (Fujita et  al., 2014; Hsieh et  al., 2018).
While cellular mechanisms for mycobacterial infection, such 
as pathogenesis and immune response, have been relatively well 
studied, the studies have been limited to single mycobacterial 
species. Therefore, the phenotypic and functional alterations of 
immune cells are not yet clearly understood in MAH and other 
microorganism co-infection. Dendritic cells (DCs), as professional 
antigen presenting cells linking innate and acquired immunity, 
prime T cells after migration to secondary lymph node, and 
induce subsequent T cell responses (Jiao et  al., 2002; Kim et  al., 
2017). In other words, the initial immune response that MAH 
and other microorganisms encounter may take place in DCs, 
which ultimately determine the direction of T cell response (Kim 
et  al., 2017). Toll-like receptors (TLRs) expressed on dendritic 
cell surfaces play an important role in recognizing specific bacterial, 
viral, and fungal structural molecules known as pathogen-associated 
molecular patterns (PAMPs) and initiating innate immune responses 
(Mogensen, 2009; Feng et  al., 2019). TLRs are also known to 
play a pivotal role in mycobacterial infections (Mahla et  al., 
2013). TLR2 has been reported to be  a major receptor that 
plays an important role in the recognition of major mycobacterial 
surface components, such as lipoprotein and lipoarabinomannan, 
and in the control of M. avium infection (Yoshimura et  al., 
1999; Jones et  al., 2001). Other TLRs have also been shown to 
recognize M. avium and induce specific immune responses. TLR4, 
which is known as a receptor for Gram-negative bacterial LPS, 
is involved in signal transduction via the heat-labile cell wall 
proteins of mycobacteria (Quesniaux et  al., 2004). TLR6 and 
TLR9 have also been reported to recognize lipoproteins and 
mycobacterial DNA and induce a host inflammatory response 
against mycobacteria (Bafica et  al., 2005; Marinho et  al., 2013). 
Additionally, various TLR agonists are also used as agents to 
mimic the mechanism of immune-cell stimulation by microbial 
signals (Feng et  al., 2019); for example, Pam3CSK4 (mimicking 
bacterial lipopeptide; agonist of TLR1/2) (Werling et  al., 2009), 
polyinosinic:polycytidylic acid (poly I:C, a synthetic double-stranded 
RNA (dsRNA); agonist of TLR3) (Matsumoto and Seya, 2008), 
lipopolysaccharide (LPS, a cell-wall component of Gram-negative 
bacteria; agonist of TLR4) (Bryant et  al., 2010), imiquimod (a 
synthetic imidazoquinolone amine, which has potent immune 
response modifier activity; agonist of TLR7) (Sauder, 2000), and 
CpG oligodeoxynucleotide (CpG ODN, short single-stranded 
synthetic DNA molecule; agonist of TLR9) (Bauer et  al., 2001).
and TLR2 were involved. Expression of Cox2 and PGE2 increased along with IL-10 while 
that of IL-10 was inhibited by their selective inhibitors celecoxib and anti-EP2 antibody, 
respectively. Thus, the tolerogenic phenotypes of MAH/LPS-treated DCs were proven to 
be induced by Cox-2/PGE2-dependent EP2 signaling as the main mechanism. These 
findings may provide important clues that the tolerogenic cascade in MAH-infected DCs 
induced by TLR 4 signaling can alter host immune response.
Keywords: Mycobacterium avium subspecies hominissuis, dendritic cells, interleukin-10, toll-like receptor4, 
Cox-2/PGE2 signaling, EP2 receptor
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In the present study, we  aimed to analyze the immune 
response of DCs by stimulating with various TLR agonists to 
mimic co-infection, ultimately to identify T cell responses in 
MAH-infected DCs. We  described a specific immune response 
of MAH-infected DCs in response to the various TLR stimuli 
and explored a major mechanism driving it. Our results provide 
important clues for the identification of complex immune 
mechanisms activated by MAH co-infection.
MATERIALS AND METHODS
Cell Culture
Bone marrow cells isolated from WT, TLR2 knockout (TLR2−/−), 
and TLR4−/− mice (C57BL/6 backgrounds, Jackson Laboratory, 
Bar Harbor, ME, USA) at 6–7  weeks of age was cultured at 
37°C in the presence of 5% CO2 using RPMI medium (GIBCO, 
Carlsbad, CA, USA) supplemented with 20  ng/ml GM-CSF 
(JW Creagene, Gyeonggi, Korea), 10% fetal bovine serum (FBS, 
Lonza, Basel, Switzerland), and 1% antibiotics (penicillin/
streptomycin, Lonza). On day eight, the CD11c+ cell fraction 
was labeled with a bead-conjugated anti-CD11c monoclonal 
antibody (mAb; Miltenyi Biotec, San Diego, CA, USA) and 
separated by sequential passages using LS columns (Miltenyi 
Biotec). Purity of the selected bone marrow-derived DCs 
(BMDCs) CD11c+ fractions was >95%.
Cytokine Analysis in Culture Supernatants
To investigate the cytokine pattern induced in MAH-infected 
BMDCs by treatment with TLR ligands, selected BMDCs were 
infected with MAH 104 [multiplicity of infection (MOI) of 1] 
for 2  h prior to treatment with Pam3CSK4 (TLR2 ligand), 
poly I:C (TLR3 ligand), LPS from Escherichia coli O111:B4 
(TLR4 ligand), imiquimod (R837, TLR7 ligand), and ODN1826 
(TLR9 ligand) for 24  h at 37°C. To investigate the cytokine 
pattern induced in BMDCs exposed to TLR ligands by infection 
with MAH 104, BMDCs were treated with each TLR ligand 
(TLR2, 3, 4, 7, and 9) for 2  h prior to infection with MAH 
104 for 24 h at 37°C. Finally, to investigate the cytokine pattern 
induced by co-treatment with MAH 104 and TLR stimulators 
(TLR ligands, P. aeruginosa PA01, or P. aeruginosa NCCP14781), 
BMDCs were treated with MAH 104 and TLR ligands, 
P. aeruginosa PA01 and TLR ligands, or P. aeruginosa NCCP14781 
and TLR ligands (representative Gram-negative bacteria; MOI 
of 0.1, 0.5, and 1) for 24  h at 37°C. To determine cytokine 
concentrations, culture supernatants were analyzed using the 
sandwich ELISA kit (eBioscience, San Diego, CA, USA) according 
to the manufacturer’s instructions. All TLR ligands were obtained 
from Invivogen (San Diego, CA, USA).
Cell Viability Assay
For Annexin V and PI staining, BMDCs were infected with 
MAH (MOI of 1) in the presence or absence of LPS (100 ng/ml) 
at 37°C. After 24  h, the cells were harvested, washed twice with 
PBS, and stained using Annexin V and PI apoptosis Detection 
kit (BD Bioscience, San Jose, CA, USA) according to the 
manufacturer’s instructions. The cells were analyzed using a LSRII 
flow cytometer (Becton Dickinson, San Jose, CA, USA). Under 
the same culture conditions for Annexin V and PI staining, Cell 
Counting Kit-8 (CCK-8) reagent (Dojindo Laboratories, Tabaru, 
Japan) was added according to the manufacturer’s instructions 
to each well for 1  h at 37°C. Viable cells were analyzed by the 
absorbance at 450  nm, using a microplate ELISA reader.
Expression of Surface Molecules for 
Dendritic Cells
The cells (non-, LPS-, MAH-, MAH/LPS-treated DCs) were 
harvested, washed twice with PBS, and stained using anti-
CD11c, anti-CD80, anti-CD86, anti-MHC-I, and anti-MHC-II 
mAbs for 30  min at 4°C. Thereafter, cells were washed three 
times with PBS, analyzed using a LSRII flow cytometer, and 
examined using FlowJo software. All surface antibodies were 
obtained from eBioscience.
Intracellular Cytokine Staining
Stimulated cells were treated with GolgiPlug for 12  h, stained 
with anti-CD11c Ab for 20  min at room temperature (RT), 
and then fixed and permeabilized with a Cytofix/Cytoperm 
kit (BD Bioscience) following the manufacturer’s instructions. 
Next, anti-TNF-α (eBioscience), anti-IL-12p70 (eBioscience), 
and anti-IL-10 (eBioscience) Abs were stained with fluorescein-
conjugated secondary Abs in a permeabilization buffer and 
analyzed using a LSRII flow cytometer.
Antigen-Presenting Ability
To investigate the differences in peptide-MHC-I and -MHC-II 
complex formations in the absence and presence of MAH 
infection, cells were stimulated with either no treatment 
(non), LPS, MAH, or LPS and MAH, in the presence of 
500  μg/ml OVA protein or 25  μg/ml Eα44–76 peptide 
(RLEEFAKFASFEAQGALANIAVDKANLDVMKKR; underlined 
sequence bound to MHC-II). OVA257–264 peptide (SIINFEKL) or 
Eα52–68 peptide (ASFEAQGALANIAVDKA) acts as a positive 
control for peptide formations of MHC-I or MHC-II, respectably. 
After 24  h of treatment, each cell was stained with anti-CD11c, 
anti-H-2Kb (SIINFEKL, eBioscience), or anti-I-Ab-Eα52–68 (Y-Ae; 
ASFEAQGALANIAVDKA, eBioscience) mAbs for 30 min at 4°C. 
Data were collected on LSRII and analyzed using FlowJo software. 
All peptides were synthesized by AbFrontier (Seoul, Korea).
Mixed Lymphocyte Reaction
Each single-cell suspension, isolated from the spleens of 
OVA-specific T cell receptor transgenic mice (OT-I and OT-II 
mice from C57BL/6 backgrounds) and BALB/C mice were 
labeled with bead-conjugated anti-CD4 and anti-CD8 mAbs 
(Miltenyi Biotec) and separated by sequential passaging using 
LS columns. Selected cells were stained with CFSE (5  μM, 
eBioscience) at 37°C and then washed with PBS (supplemented 
with 2% FBS) after 15  min. Next, in the presence or absence 
of OVA-specific OVA323–339 or OVA257–264 treatments, the cells 
(non-, LPS-, MAH-, MAH/LPS-treated DCs) were co-cultured 
with CFSE-labeled T cells (from naïve BALB/C, OT-I, or OT-II 
mice) at a DC to a T cell ratio of 0.5:1. After 3  days of 
co-culture, cells were harvested and stained with anti-CD4 
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and anti-CD8 mAbs (eBioscience). Data were collected on 
LSRII and analyzed using the FlowJo software. Cytokines, 
including IFN-γ and IL-2, were analyzed from the culture 
supernatants using cytokine-specific ELISA kits (eBioscience), 
following the manufacturer’s instructions.
Heat and Paraformaldehyde  
Inactivation for Mycobacterium avium 
subspecies hominissuis
In cell cultures with MAH, MAH were killed either by heating 
at 100°C for 30  min or by a 1-h incubation at RT in 4% 
(w/v) paraformaldehyde (PFA). Bacteria inactivated with PFA 
were extensively washed off with PBS. In the presence or 
absence of heat or PFA inactivation, the production of cytokines 
in non-, LPS-, MAH-, and MAH/LPS-treated DCs was analyzed 
using ELISA.
Immunoblot Analyses
For the cytosolic fraction, cells were lysed with RIPA lysis 
buffer (Pierce, Rockford, IL, USA). The subsequent steps were 
carried out as previously described (Kim et  al., 2013). Western 
blotting Abs and HRP-conjugated anti-rabbit Abs were obtained 
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA) 
and Sigma-Aldrich (St. Louis, Mo, USA), respectively.
Treatment of Pharmacological Inhibitor 
and PGE2 Receptor Blockers
Following pre-treatment with Cox-2 inhibitor (celecoxib; 1 μM) 
or PGE2 receptor blockers (1 μg/ml each of anti-EP2 and -EP4 
mAb) for 1  h, cells were infected with MAH (MOI of 1) in 
the presence or absence of LPS treatment for 24 h at 37°C, and 
IL-10 concentration was evaluated by ELISA. Cox-2 inhibitor 
and PGE2 receptor blockers were obtained from Sigma-Aldrich 
and Abcam (Cambridge, MA, USA), respectively.
Statistical Analysis
Levels of significance of the differences between samples were 
determined by Tukey’s multiple comparison test and unpaired 
t-test using a statistical software (GraphPad Prism Software, 
version 5; GraphPad Software, San Diego, CA, USA). 
We  performed a normality test using Shapiro-Wilk test. At 
the 0.05 level, all data were significantly drawn from a normally 
distributed population. The data in the graphs are expressed 
as the means. Results were considered to be statistically significant 
at *p  <  0.05, **p  <  0.01, or ***p  <  0.001.
RESULTS
Toll-Like Receptor4 Agonist Stimulation of 
Mycobacterium avium subspecies 
hominissuis-Infected Dendritic Cells 
Induces Marked Interleukin-10 Production
TLRs play key roles in host defense against various pathogens, 
which may contribute to the PAMP-induced signaling pathways 
(Mogensen, 2009). In order to study how co-infection of MAH 
and various pathogens affects cytokine production in DCs, 
we  first confirmed the regulation of cytokine production (pro- 
and anti-inflammatory cytokines) in DCs following MAH infection 
for 2 h prior to stimulation with TLR agonist for 24 h (Figure 1A). 
Interestingly, MAH-infected DCs dramatically increased the 
levels of anti-inflammatory cytokine IL-10  in the presence of 
TLR4 agonist (LPS) stimulation, although this cytokine level 
was not significantly different in the presence of other TLR 
signaling molecules. The increased patterns of TNF-α and 
IL-12p70 levels were not shown. Next, we analyzed the regulation 
of cytokine production following TLR agonist treatment for 
2  h prior to infection with MAH for 24  h (Figure 1B). TNF-α 
and IL-12p70 production in DCs, induced by the treatment 
of TLR2, 3, 4, 7, and 9 agonists, were strongly increased by 
MAH infection; IL-10 production in DCs, induced by the 
treatment of TLR3, 4, 7, and 9 agonists, was increased by 
MAH infection, but not in TLR2-treated DCs. Finally, we analyzed 
cytokine production in DCs following treatment with both 
MAH and TLR ligands (Figure 1C). As shown in Figure 1C, 
MAH-infected DCs had considerably higher levels of the anti-
inflammatory cytokine IL-10  in the presence of TLR4 signaling 
(LPS stimulation), although this cytokine level was not significantly 
different in the presence of other TLR signaling molecules. 
TNF-α and IL-12p70 production, depicted in Figures 1A,C, 
showed similar patterns for treatment of all TLR agonists, 
although IL-10 levels strongly increased in Figure 1C (LPS 
treatment condition) than in Figures 1A,B. Based on these 
results, to investigate the role of excessive IL-10 production in 
DCs co-infected with MAH and TLR-stimulations, the method 
in Figure 1C was selected for further investigation. We  also 
confirmed that the remarkable enhancement in IL-10 production 
in MAH-infected DCs exposed to LPS was not due to cytotoxicity, 
since there was no difference in Annexin V/PI positive cells 
and LDH release (Figures 1D,E). We  also identified the above 
results using P. aeruginosa, a Gram-negative organism, which 
is reported to be  a major co-infecting agent in patients with 
NTM-PD (Wickremasinghe et  al., 2005), in order to confirm 
the specific immune response of MAH-infected DCs in real 
co-infection. P. aeruginosa PA01 and P. aeruginosa NCCP14781 
were tested with the third method (followed in Figure 1C), 
and expression of IL-10 was explosively increased in the MAH/P. 
aeruginosa-infected DC (Supplementary Figure S1).
Mycobacterium avium subspecies 
hominissuis-Infected Dendritic Cells 
Induce Tolerogenic Phenotypes in the 
Presence of Toll-Like Receptor4 Signaling
The IL-10 production level is higher in tolerogenic DCs compared 
to in inflammatory DCs (Raker et al., 2015). Thus, we hypothesized 
that IL-10 production by MAH-infected DCs, upon stimulation 
with LPS, induces tolerogenic phenotypes. To validate this 
hypothesis, we  analyzed the expression of surface molecules 
(CD80, CD86, MHC-I, and MHC-II) in each stimulation condition 
(non-, LPS-, MAH-, MAH/LPS-DCs) across the time-points 
(12 and 24  h). MAH-infected DCs exposed to LPS showed a 
lower expression of MHC-II than MAH-infected DCs at 24  h, 
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but there was no significant change in CD80, CD86, and MHC-I 
expression (Figure 2A) at all time-points. These phenomena 
were not observed at an earlier time point (6 h; data not shown). 
We  also measured the extracellular and intracellular cytokine 
levels in time-dependent manner. A significant up-regulation 
of extracellular IL-10 production occurred in MAH-infected 
DCs exposed to LPS in a time-dependent manner (Figure 2B). 
These results were confirmed by intracellular staining of cytokines, 
which revealed that MAH-infected DCs exposed to LPS 





FIGURE 1 | MAH-infected DCs induced high-level anti-inflammatory cytokine secretion, but no pro-inflammatory cytokine, during TLR4 agonist stimulation.  
(A,B,C) Immature DCs were treated with PBS (CON), various TLR agonists, and MAH (at a MOI of 1) under three conditions. After 24 h, culture supernatants were 
collected, and IL-12p70, TNF-α, and IL-10 production analyzed using ELISA. (A) DCs were treated with PBS (CON) and various TLR agonists after 2-h MAH infection. 
(B) DCs were treated with PBS (CON) and MAH after 2-h treatment with various TLR agonists. (C) DCs were treated with PBS (CON), various TLR agonists, MAH, or 
MAH with various TLR agonists for 24 h. (D,E) DCs were treated with PBS (CON), LPS, MAH, or MAH with LPS (100 ng/ml) for 24 h. (D) After incubation, apoptotic 
and necrotic cell deaths were measured by PI and Annexin V assay. (E) The surviving cells were quantified with CCK-8 assay. The data are expressed as the 
mean ± SD of 4 samples per treated condition. One representative plot out of three independent experiments is shown. *p < 0.05, **p < 0.01, or ***p < 0.001.
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but lower intracellular IL-12p70 expression, than LPS-treated 
DCs (Figure 2C). Since antigen-presenting ability is influenced 
by the expression of IL-10 and MHC class molecules regulated 
by DCs, we  analyzed the antigen-presenting ability of 
MAH-infected DCs exposed to LPS signaling by the anti-Y-Ae 
mAb, which directly reacts with the Eα52–68 peptide MHC-II, 
and the anti-25-D1.16 mAb, which recognizes the OVA257–264 
peptide bound to H-2Kb of MHC-I (Figure 3). In the study 
of antigen-presenting ability of non-treated DCs, MAH-infected 
DCs, LPS-treated DCs, and MAH-infected DCs exposed to LPS 
A
B C
FIGURE 2 | MAH infection reduced the expression of MHC class II molecules, and facilitated the production of IL-10 in presence of LPS treatment. (A,B) DCs were 
treated with PBS (CON), LPS, MAH, or LPS with MAH for the indicated times, and cells and supernatants were harvested. (A) Cells were stained with surface Abs 
(anti-CD80, anti-CD86, anti-MHC-I, and anti-MHC-II) of DCs, and analyzed by flow cytometry. DC population was drawn based on characteristic FSC and SSC 
patterns. Matured DCs were further gated to obtain CD11c+CD80+, CD11c+CD86+, CD11c+MHC-I+, and CD11c+MHC-II+. Dot blot for the expression of surface 
molecules is shown as a representative plot out of three independent experiments. Bar graphs are expressed as the mean ± SD of 3 samples per treated condition. 
(B) IL-12p70, TNF-α, and IL-10 production in the culture supernatants was analyzed by ELISA. Bar graphs are expressed as the mean ± SD of 3 samples per 
treated condition. (C) DCs were treated with PBS (CON), LPS, MAH, or LPS with MAH in presence of GolgiPlug. After 12 h, cells were fixed/permeabilized and 
stained with anti-TNF-α, anti-IL-12p70, and anti-IL-10 mAbs and analyzed by flow cytometry. Intracellular cytokine levels were drawn based on the CD11c+TNF+, 
CD11c+IL-12p70+, and CD11c+IL-10+ cells. One representative plot, out of four independent experiments, is shown. *p < 0.05, **p < 0.01, or ***p < 0.001.
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were treated with OVA protein or Eα44–76 peptide for 24  h, 
and then cells were stained with anti-Y-Ae (Figures 3A,C) or 
anti-25-D1.16 (Figures 3B,D) mAbs, respectively. Eα52–68 and 
OVA257–264 were used as the positive control for MHC-II or 
MHC-I bound peptides. As expected, a significantly lower 
percentage of OVA257–264/MHC-II complexes (Y-Ae-positive cells) 
were present in the MAH-infected DCs exposed to LPS compared 
to that in the MAH-infected DCs, or LPS-treated DCs 
(Figures 3A,C); a decrease of Eα52–68/MHC-I complex (25-D1.16-
positive cells) was not observed (Figures 3B,D). These results, 
together with the strong increase in IL-10 production, reduction 
of MHC-II expression, and MHC-II antigen presentation, indicated 
that MAH infection endows DCs with a tolerogenic property 
in the presence of TLR4 signaling.
Mycobacterium avium subspecies 
hominissuis-Infected Dendritic Cells 
Reduce the Proliferation of CD4+ T Cells  
in the Presence of Toll-Like  
Receptor4 Signaling
As a next step, we investigated the reduction of T cell proliferation, 
induced during MAH-infection of DCs exposed to LPS, which 
can block the proliferation of naïve T cells (Domogalla et al., 2017). 
Thus, we  performed a mixed lymphocyte reaction assay using 
OVA-specific T cells (Figures 4A,B) and allogeneic T cells 
(Figures 4C,D). Further details regarding the mixed lymphocyte 
reaction assay is provided in the section “Materials and Methods.” 
Interestingly, MAH-infected DCs exposed to LPS reduced the 
proliferation and Th1-type cytokine production (IFN-γ and 
IL-2) of OVA-specific (Figure 4A) and allogeneic (Figure 4C) 
CD4+ T cells compared to MAH-infected DCs and/or LPS-treated 
DCs, although not in CD8+ T cells (Figures 4B,D). These 
findings indicated that MAH-infected DCs exposed to LPS 
lead to the inhibitory effect of CD4+ T cell proliferation.
Interleukin-10 Neutralization for 
Mycobacterium avium subspecies 
hominissuis-Infected Dendritic Cells 
Exposed to LPS Induces Neither 
Tolerogenic Dendritic Cell Phenotypes nor 
Reduction in CD4+ T Cell Proliferation
Based on the above results, we  hypothesized that if IL-10 
production, induced by MAH-infected DCs exposed to LPS, 




FIGURE 3 | MAH infection reduced the antigen presenting ability of MHC class II molecules in LPS-treated DCs. (A,C) DCs were treated with PBS (CON), LPS, 
MAH, or LPS with MAH, and then exposed to Eα44–76 peptide for 24 h. Cells were harvested and stained with ani-CD11c and anti-Y-Ae mAbs. (B,D) DCs were 
treated with PBS (CON), LPS, MAH, or LPS with MAH, and then exposed to OVA protein for 24 h. Cells were harvested and stained with ani-CD11c and anti-
25-D1.16 mAbs. Histogram and bar graphs for expression of Eα52–68/I-Ab (A,C) and OVA257–264/H-2Kb (B,D) complexes in CD11c+ cells were analyzed by flow 
cytometry. One representative plot out of three independent experiments is shown. *p < 0.05, or **p < 0.01. non: non-treated DCs, Eα52–68: Eα52–68 peptide-treated 
DCs (positive control for MHC-II presenting), OVA257–264: OVA257–264 peptide-treated DCs (positive control for MHC-I presenting).
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and reducing CD4+ T cell proliferation, the absence of IL-10 
signaling should restore an activated DC phenotype and CD4+ 
T cell proliferation. First, to investigate whether the IL-10 
induced by MAH-infected DCs exposed to LPS induces 
phenotypic and functional changes, we  treated MAH-infected 
cells with an anti-IL-10 mAb and evaluated cytokine production, 
surface molecule expression, and antigen-presenting ability 
exposed to LPS stimulation. MAH-infected DCs exposed to 
LPS significantly abrogated IL-10 production, although IL-12p70 
levels were increased in the presence of anti-IL-10 mAb. TNF-α 
production was not significantly different in the presence of 
anti-IL-10 mAb (Figure 5A). Moreover, incubation of the LPS/
MAH-infected DCs (MAH-infected DCs exposed to LPS) with 
an anti-IL-10 mAb restored their MHC-II expression levels 
(Figure 5B, Supplementary Figure S2A) as well as antigen-
presenting ability (Figure 5C, Supplementary Figure S2B) of 
MHC-II. Furthermore, we  evaluated the capacity of IL-10-





FIGURE 4 | MAH infection reduced the capacity of LPS-activated DCs to induce CD4+ T cell proliferation. (A,B) OVA-specific T cells (CD4 and CD8) isolated from 
OT-I and OT-II mice were stained with CFSE, co-cultured for 96 h with DCs treated with PBS (CON), MAH, or LPS with MAH, and then exposed to OVA323–339 or 
OVA257–264 peptide. Cells were harvested and stained with ani-CD4 or anti-CD8 mAbs. To analyze T cell proliferation, lymphocyte gate was first drawn based on the 
cell size and granularity. The proliferated T cells were further gated to obtain CD4+CFSE− and CD8+CFSE−. The proliferation and cytokine production (IFN-γ and IL-2) 
of OVA-specific CD4+ (A) and CD8+ T cells (B) were then assessed by flow cytometry and ELISA, respectively. (C,D) CD4 and CD8 T cells isolated from BALB/C 
(allogeneic mice) were stained with CFSE, and co-cultured for 96 h with DCs treated with PBS (CON), MAH, or LPS with MAH. The proliferation and cytokine 
production (IFN-γ and IL-2) of CD4+ (C) and CD8+ T cells (D) were then assessed by flow cytometry and ELISA, respectively. Dot plots for CD4 and CD8 T cell 
proliferation are shown as one representative plot out of three independent experiments. Bar graphs are expressed as the mean ± SD of 5 samples per treated 
condition. IFN-γ and IL-2 production in the culture supernatants were analyzed by ELISA. Bar graphs are expressed as the mean ± SD of 3 samples per treated 
condition. *p < 0.05, **p < 0.01, or ***p < 0.001. non: non-treated DCs.
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allogenic CD4+ T cells using the same experimental conditions 
described in Figure 4C. As shown in Figure 5D, Supplementary 
Figure S2C, IL-10-neutralized LPS/MAH-infected DCs restored 
CD4+ T cell proliferation compared to rat IgG (isotype control 
Ab)-treated LPS/MAH-infected DCs. Collectively, these results 
indicated IL-10 signal as a key player in the tolerogenic 
phenotypes and activities induced by the MAH-infected DCs 
exposed to LPS.
Live Mycobacterium avium subspecies 
hominissuis Infection in Dendritic Cells is 
Essential for Both Toll-Like Receptor2 and 
Toll-Like Receptor4 Signaling-Mediated 
Interleukin-10 Production
Next, we examined whether excessive IL-10 production of LPS/




FIGURE 5 | IL-10 neutralization reduced the tolerogenic function induced by MAH/LPS-primed DCs. (A,B) DCs were treated with PBS (CON), LPS, MAH, or LPS 
with MAH and then pulsed with a neutralizing anti-IL-10 mAb or rat IgG (isotype control) for 24 h. (A) IL-12p70, TNF-α, and IL-10 production in the culture 
supernatants were analyzed by ELISA. (B) Cells were stained with surface Abs (anti-CD80, anti-CD86, anti-MHC-I, and anti-MHC-II) of DCs and analyzed by flow 
cytometry. Bar graphs are expressed as the mean ± SD of five samples per treated condition. (C,D) In the presence of neutralizing ani-IL-10 mAb or rat IgG, DCs 
were treated with PBS (CON), LPS, MAH, or LPS with MAH and then exposed to Eα44–76 peptide or OVA protein for 24 h. Cells were harvested and stained with 
ani-CD11c, anti-Y-Ae, or anti-25-D1.16 mAbs. Bar graph for expression of Eα52–68/I-Ab complexes was analyzed by flow cytometry. The bar graph is expressed as 
the mean ± SD of four samples per treated condition. (D) CD4+ T cells isolated from BALB/C mice (allogeneic mice) were stained with CFSE, and co-cultured for 
96 h with DCs treated with PBS (CON), MAH, or LPS with MAH in the presence or absence of a neutralizing ani-IL-10 mAb or rat IgG. The proliferation of CD4+ was 
then assessed by flow cytometry. Bar graph is expressed as the mean ± SD of five samples per treated condition. All data are shown as a representative plot out of 
three independent experiments. *p < 0.05, or ***p < 0.001. non: non-treated DCs.
Kim et al. Induced Tolerogenic DC Upon MAH/TLR-Stimulation
Frontiers in Microbiology | www.frontiersin.org 10 August 2019 | Volume 10 | Article 1795
DCs were exposed to inactivated MAH, killed by heat or PFA 
treatment, in the presence of LPS. Interestingly, lower levels 
of IL-10 were observed in the LPS/inactivated MAH-infected 
DCs than in LPS/MAH-infected DCs (Figure 6A). Moreover, 
we  determined the regulation of IL-10 production in DCs 
isolated from WT, TLR2−/−, and TLR4−/− mice, since TLR2 
and TLR4 receptors play critical roles in host immune system 
against MAH infection (Feng et al., 2003; Bhatnagar and Schorey, 
2007). As shown in Figure 6B, the expression of TNF-α, 
IL-12p70, and IL-10 was induced by MAH-infected DCs exposed 
to LPS in the same manner as LPS-alone treatment in TLR2−/− 
and as MAH-alone infection in TLR4−/−. However, unlike other 
cytokines such as TNF-α and IL-12p70, IL-10 production was 
remarkably increased in the WT. These results suggested that 
both TLR2 and TLR4 signaling are essential for excessive IL-10 
production induced by MAH-infected DCs exposed to LPS.
Activation of Cox-2 Pathways Mediates 
Excessive Interleukin-10 Production in 
Mycobacterium avium subspecies 
hominissuis-Infected Dendritic Cells 
Exposed to LPS
Mitogen-activated protein kinase (MAPK), nuclear factor kappa-B 
(NF-κB), and cyclooxygenase-2 (Cox2)/PGE2 signals regulate 
pro- and anti-inflammatory cytokine production during DC 
maturation (Harizi et  al., 2002; Gabrysova et  al., 2014). To 
examine whether these signals are involved in increased IL-10 
production of LPS/MAH-infected DCs, the phosphorylated MAPKs 
(p-ERK, p-JNK, and p-p38), the phosphorylation/degradation 
of IκB-α, and Cox2 activation were investigated by western 
blot analysis (Figure 7A). LPS/MAH-infected DCs showed 
rapid ERK, JNK, and p38 phosphorylation compared to 
LPS-treated or MAH-infected DCs at early exposure time 
(15  min), but not in later exposure times (30 and 60  min). 
These results showed that MAPK and NF-κB signals are not 
the major pathways for IL-10 production, since IL-10 produced 
by LPS/MAH-infected DCs were not observed in 6-h exposure 
time. Interestingly, LPS/MAH-infected DCs promoted Cox2 
activation and PGE2 expression compared to LPS-treated or 
MAH-infected DCs (Figures 7B,C). To confirm the involvement 
of Cox2/PGE2 activation in excessive IL-10 production, we next 
treated LPS/MAH-infected DCs with specific Cox2 inhibitor 
(celecoxib) and PGE2 receptor blockers (anti-EP2 and -EP4 
mAbs) and then analyzed IL-10 production. Treatment of Cox2 
inhibitor and EP2 blocker significantly abrogated IL-10 
production in LPS/MAH-infected DCs (Figures 7D,E), suggesting 
Cox2/PGE2-dependent EP2 signaling as the main pathway for 
IL-10 production induced by MAH-infected DCs exposed 
to LPS.
DISCUSSION
To date, pathogenesis and immune phenomena have been 
studied using single species of mycobacteria and applied to 
treatment guidelines; these studies have usually been limited 
to MTB. Here, we  investigated the specific immune response 
and related major mechanisms by stimulating the different 
TLR agonists to mimic co-infection in MAH-infected DCs. 
A
B
FIGURE 6 | Live MAH induced IL-10 secretion via TLR2 receptor. (A) Maturation of the MAH vacuole is arrested in DCs. Live- (MAH), PFA fixed- (PFA-MAH), and 
heat-killed MAH (Boiled MAH)-infected DCs were treated in the presence or absence of LPS for 24 h. Culture supernatants were collected and the levels of TNF-α, 
IL-12p70, and IL-10 were determined by ELISA assay. (B) Bone marrow cells were purified from WT, TLR2−/−, and TLR4−/− mice. WT-, TLR2−/−-, and TLR4−/−-DCs 
differentiated from each bone marrow cells were treated with PBS (CON), LPS, MAH, or LPS with MAH for 24 h. After that, the secretion of TNF-α, IL-12p70, and 
IL-10 on DCs was measured by ELISA. Bar graph is expressed as the mean ± SD of four samples per treated condition. All data are shown in one representative 
plot out of three independent experiments. *p < 0.05, **p < 0.01, or ***p < 0.001. non: non-stimulated condition.
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MAH-infected DCs strongly increased IL-10 production when 
treated with the TLR4 agonist LPS compared to treatment 
with various other TLR agonists. LPS treatment induced 
tolerogenic phenotypes in MAH-infected DCs by significantly 
reducing the expression of MHC class II and MHC class 
II-antigen presentation and significantly increasing the production 
of extracellular and intracellular IL-10, thus inhibiting CD4+ T 
cell proliferation along with decreased IFN-γ and IL-2. The 
use of an anti-IL-10 neutralizing Ab also confirmed the recovery 
of all tolerogenic DC phenotypes described above. Interestingly, 
the expression of these tolerogenic DCs was observed following 
infection with live MAH, but not with inactivated MAH, and 
when TLR2 and TLR4 were co-involved. In addition, the 
tolerogenic phenotype in which MAH-infected DCs were induced 
by LPS treatment revealed that Cox2/PGE2-dependent EP2 
signaling is a key pathway.
As shown in Figure 1A, the expression changes of TNF-α, 
IL-12p70, and IL-10 following TLR2, TLR3, TLR4, TLR7, and 
TLR9 agonist treatment in MAH-infected DCs were analyzed. 
Although there were differences in levels, TLR3 and TLR4 
stimulation particularly decreased IL-12p70 expression and 
remarkably elevated IL-10 expression in MAH-infected DCs. 
There was a substantial increase in IL-10 expression following 
TLR4 stimulation (Figure 1C). As mentioned in the section 
“Introduction,” many studies have suggested P. aeruginosa, a 
Gram-negative organism, as the most frequent co-infecting 
agent in NTM infection (Wickremasinghe et  al., 2005). TLR4 
is one of the representative TLRs in P. aeruginosa, which has 
been shown to affect susceptibility phenotypes, such as increased 
inflammatory cytokine production, decreased iNOs and 
β-defensin-2 production, and bacterial elimination in TLR4-
deficient mice (McIsaac et  al., 2012). For further clarification, 
we  identified changes in the expression of TNF-α, IL-12p70, 
and IL-10 in MAH-infected DCs co-infected with P. aeruginosa, 
and in particular, the expression of IL-10 dramatically increased, 
confirming that TLR4 signaling in MAH infected cells showed 
the same result as in the actual infection with Gram-negative 
bacteria (Supplementary Figure S1). In addition, we  analyzed 
the expression changes of IL-10 production in TLR2−/-DCs 





FIGURE 7 | MAH-induced IL-10 production in LPS-treated DCs involved the activation of Cox-2/PGE2 signaling pathways. (A,B) DCs were treated with PBS 
(CON), LPS, MAH, or LPS with MAH for indicated times. Protein levels of phospho-ERK (p-ERK), p-JNK, p-p38, p-IkB-α, IkB-α, and COX-2 in cell lysate were 
evaluated by western blot analysis. β-actin: loading control for cytosolic fractions. (C) After stimulation for 24 h, supernatants were collected, and levels of PGE2 
were determined by ELISA assay. (D,E) DCs were cultured at 37°C for 1 h with Cox-2 inhibitor (D; celecoxib, 10 μM) or PGE2 receptor blockers (E; anti-EP2 and 
-EP4 Abs) for 1 h, prior to treatment with PBS, LPS, MAH, or LPS with MAH for 24 h. Culture supernatants were collected, and IL-10 production analyzed using 
ELISA. ***p < 0.001 or **p < 0.01.
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The level of IL-10 expression was similar in that in MAH/
LPS-infection and LPS-treatment of TLR2−/− DCs and in MAH/
LPS-infection and MAH-infection of TLR4−/− DCs, whereas 
IL-10 production was strongly increased in MAH/LPS-infection 
in WT DCs. This level of IL-10 expression was greater than 
the sum of IL-10 production due to either MAH or LPS alone. 
These results collectively indicate that MAH infection and LPS 
stimulation interact and produce a synergistic reaction. TLR2 
and TLR4 are thought to act together to express the phenotype 
of IL-10-expressing tolerogenic DC.
There have been several previous studies in which multiple 
TLRs have been shown to work together to induce totally 
new immune responses or to distort the existing immune 
responses. Along with TLR2, which is a major synergistic 
receptor that recognizes mycobacteria, TLR9 is essential for 
inducing Th1 responses (Bafica et al., 2005); however, according 
to Holscher et  al. (2008), TLR2, TLR9, and MyD88 signaling 
has little influence on the induction of Th1 responses in MTB 
infection (Holscher et  al., 2008). TLR6, TLR9, and MyD88 
signaling has been shown to regulate M. avium infection; 
MyD88, in particular, plays an essential role in inducing a 
protective immune response (Carvalho et  al., 2011; Marinho 
et  al., 2013). In addition, Srivastava et  al. (2009) had reported 
that MTB acts on TLR2 and dendritic cell-specific ICAM-3 
grabbing non-integrin receptor (DC-SIGNR), and that 
suppressors of cytokine signaling (SOCS) was induced by the 
differential control of the two receptors depending on MTB 
virulence, thus impairing the defense against MTB (Srivastava 
et  al., 2009). More importantly, TLR4,2-primed DCs enhanced 
IL-10 production by altering the balance of signaling pathways 
(via p38 MAPK, ERK1/2, and TNFR-associated factor 3) 
following TLR4 stimulation (Yanagawa and Onoe, 2007). MAPK 
p38 has been well established to be  first involved in the 
production of IL-10 and IL-12  in response to LPS stimulation 
(Park et al., 2005). However, following TLR4 stimulation, IL-10 
production is more significantly increased in TLR4,2-primed 
DCs than in TLR4-primed DCs, thereby suggesting that TLR2-
mediated signaling contributes to the enhancement of IL-10 
production capability (Yanagawa and Onoe, 2007). We  can see 
similar results in Figure 6. TNF-α was expressed at the same 
level regardless of live, inactivated, or dead MAH infection; 
however, the expression of IL-12p70 and IL-10 was confirmed 
to be  induced during the infection of live MAH (Figure 6A). 
In addition, since TLR2 and TLR4 were found to work together 
and boost the expression of IL-10 (Figure 6B), the TLR4 
agonist, LPS, and the TLR2 ligand, expressed by live MAH, 
were thought to induce tolerogenic DC.
DCs are tightly regulated so as to induce protective immune 
responses and prevent exaggerated or unwanted immune responses 
(Corinti et  al., 2001). IL-10 is an anti-inflammatory cytokine 
and a critical factor in inducing tolerogenic DCs, which subsequently 
impedes the Th1 response (Raker et  al., 2015; Kim et  al., 2017). 
The role of IL-10  in mycobacterial infection has been extensively 
studied. IL-10 has been shown to play an important role in 
immune regulation in host immunity; however, it is also known 
to be  involved in anti-mycobacterial function, which can 
survive in both macrophages and DCs (Hussain et  al., 2016). 
In the present study, the high level of IL-10 produced in LPS/
MAH-infected DCs selectively promoted tolerogenic DCs by 
reducing MHC class II and MHC class II-antigen presentation 
and consequently inhibiting CD4+ T cell proliferation and IFN-γ 
and IL-2 expression (Figures 2–5). Finally, IL-12p70 expression 
was reduced in LPS/MAH-infected DCs, while IL-12p70 
expression was restored using anti-IL-10, demonstrating that 
Th1 responses were inhibited by LPS/MAH stimulation 
(Figure 5). These findings clearly imply that the tolerogenic 
phenotype of DCs was induced by IL-10.
Various mechanisms have been reported to modulate IL-10 
production. The major signaling pathways associated with IL-10 
regulation and production include MAPKs, NF-κB, and signal 
transducer and activator of transcription-3 (STAT3) (Hussain 
et  al., 2016). In particular, MAPK p38 plays an important role 
in overall signal cascades in mycobacterial infections 
(Reiling et  al., 2001; Hussain et  al., 2016). However, in this 
study, since IL-10 was produced after 6  h of LPS stimulation 
and MAPK (ERK, JNK, and p.  38) phosphorylation only 
occurred during the early exposure time (15  min), the MAPK 
signals were obviously not the major pathway involved in IL-10 
production (Figure 7). The adapter MyD88, which acts 
downstream of TLR4, induces activation of NF-κB and MAP 
kinase using the adapter TIRAP (Takeuchi and Akira, 2010); 
TIR-domain-containing adapter-inducing interferon-β (TRIF) 
activates IRF3 as an adapter for TLR4 and TLR3 and induces 
expression of IFN-β and -α4 (Takeuchi and Akira, 2010). As 
mentioned above, TLR3 and TLR4 treatment of MAH-infected 
DCs showed similar results, indicating increased IL-10 expression 
and decreased IL-12p70 expression. Although previous studies 
have reported differences in TRIF-mediated DC maturation 
for type 1 IFN dependencies between TLR3 and TLR4 (Hu 
et  al., 2015), our results indicated the involvement of TRIF 
signaling pathway downstream of TLR3 and TLR4.
In addition to IL-10, PGE2 is also produced in DCs and 
is known to exhibit immunosuppressive effects (Harizi and 
Gualde, 2006). Moreover, PGE2 has been reported to act on 
the EP receptor, a PGE2 receptor expressed on the surface of 
DCs, to increase internal cAMP, which ultimately increases 
endogenous IL-10 production (Harizi and Norbert, 2004). Cox2 
has been reported to be  highly expressed in DCs following 
LPS stimulation and is associated with the synthesis of large 
amounts of PGE2 (Harizi et  al., 2002). Interestingly, Cox2 
activation and PGE2 expression were significantly increased 
in LPS/MAH-infected DCs compared to LPS-treated or 
MAH-infected DC alone, and the production of IL-10 was 
remarkably inhibited by celecoxib, a Cox2 inhibitor, in the 
present study (Figure 7). Therefore, IL-10 expression was 
considered to be induced by Cox2-mediated PGE2 in MAH/LPS 
infected DCs. Of the four subtypes, cAMP has been reported 
to act on EP2 and EP4, IL-10 is increased in DCs, and EP2 
increases IL-10 production in LPS-stimulated DCs (Harizi et al., 
2003; Harizi and Gualde, 2006). Our results demonstrate the 
effect of EP2 blocker in reducing IL-10 production, thereby 
suggesting Cox2/PGE2-dependent EP2 signaling as the major 
mechanism involved in IL-10 production induction by LPS 
treatment in MAH-infected DCs. Therefore, the present study 
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on tolerogenic DC phenotype, function, and related mechanisms 
induced by LPS/MAH-infected DCs may provide clues for 
understanding the altered immune responses in case of MAH 
co-infection.
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SUPPLEMENTARY FIGURE 1 |  MAH-infected DCs induced high-level anti-
inflammatory cytokine secretion during Pseudomonas aeruginosa infection. 
Immature DCs were treated with PBS (CON), MAH (at a MOI of 1), P. aeruginosa 
PA01 (at a MOI of 0.1, 0.5, and 1), P. aeruginosa NCCP14781 (at a MOI of 0.1, 
0.5, and 1), or P. aeruginosa with MAH. After 24 h, culture supernatants were 
collected, and TNF-α, IL-12p70, and IL-10 productions were analyzed using 
ELISA. The data are expressed as the mean ± SD of 4 samples per treated 
condition. ***p < 0.001.
SUPPLEMENTARY FIGURE 2 |  Gating strategy for the analysis of surface 
molecule expression, antigen presenting ability, and T cell proliferation by IL-10 
neutralization in DCs treated with LPS and MAH. (A,B) DCs were treated with 
PBS (CON), LPS, MAH, or LPS with MAH, and then pulsed with a neutralizing 
ani-IL-10 mAb or rat IgG (isotype control) for 24 h. (A) Cells were stained with 
surface Abs (anti-CD80, anti-CD86, anti-MHC-I, anti-MHC-II) of DCs, and 
analyzed by flow cytometry. This result shows the flow cytometry gating strategy 
for Figure 5B. (B) In presence of neutralizing ani-IL-10 mAb or rat IgG, DCs were 
treated with PBS (CON), LPS, MAH, or LPS with MAH, and then exposed to 
Eα44–76 peptide or OVA257–264 (positive control) for 24 h. Cells were harvested and 
stained with ani-CD11c, and anti-Y-Ae or anti-25-D1.16 mAbs. Bar graph for the 
expression of Eα52–68/I-Ab complexes was derived from flow cytometry. This result 
shows the flow cytometry gating strategy for Figure 5C. (C) CD4+ T cells isolated 
from BALB/C (allogeneic mice) were stained with CFSE, and co-cultured for 96 h 
with DCs treated with PBS (CON), MAH, or LPS with MAH, in presence or 
absence of a neutralizing ani-IL-10 mAb or rat IgG. The proliferation of CD4+ was 
then assessed by flow cytometry. This result shows the flow cytometry gating 
strategy for Figure 5D.
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